Earnings Summary

HARPOON THERAPEUTICS INC’s revenue jumped 45.33% since last year same period to $8.58Mn in the Q1 2023. On a quarterly growth basis, HARPOON THERAPEUTICS INC has generated -53.09% fall in its revenue since last 3-months.

HARPOON THERAPEUTICS INC’s net profit jumped 40.71% since last year same period to $-12.05Mn in the Q1 2023. On a quarterly growth basis, HARPOON THERAPEUTICS INC has generated 78.52% jump in its net profits since last 3-months.

HARPOON THERAPEUTICS INC’s net profit margin jumped 59.2% since last year same period to -140.38% in the Q1 2023. On a quarterly growth basis, HARPOON THERAPEUTICS INC has generated 54.2% jump in its net profit margins since last 3-months.

HARPOON THERAPEUTICS INC’s earning per share (EPS) estimates for the current quarter stand at -0.5 - a 10.71% jump from last quarter’s estimates.

HARPOON THERAPEUTICS INC’s earning per share (EPS) estimates for the current year stand at -0.5.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. HARPOON THERAPEUTICS INC’s return on assets (ROA) stands at -0.34.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. HARPOON THERAPEUTICS INC’s return on equity (ROE) stands at -2.79.